Drug reverses mental retardation caused by genetic disorder

UCLA mouse study offers hope for correcting how autism disrupts brain UCLA researchers discovered that an FDA-approved drug reverses the brain dysfunction inflicted by a genetic disease called tuberous sclerosis complex (TSC). Because half of TSC patients also suffer from autism, the findings offer new hope for addressing learning disorders due to autism. Nature Medicine publishes the findings in its online June 22 edition.

Read the whole article on Physorg

More from Physorg